Financials data is unavailable for this security.
View more
Year on year Diaceutics PLC 's net income fell from a gain of 724.00k to a loss of 1.75m despite revenues that grew 21.51% from 19.50m to 23.70m. An increase in the selling, general and administrative costs as a percentage of sales from 83.47% to 96.14% was a component in the falling net income despite rising revenues.
| Gross margin | 83.30% |
|---|---|
| Net profit margin | -10.90% |
| Operating margin | -17.00% |
| Return on assets | -6.22% |
|---|---|
| Return on equity | -7.13% |
| Return on investment | -6.90% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Diaceutics PLC fell by 3.17m. However, the company earned 1.31m from its operations for a Cash Flow Margin of 5.53%. In addition the company used 4.21m on investing activities and also paid 239.00k in financing cash flows.
| Cash flow per share | 0.027 |
|---|---|
| Price/Cash flow per share | 45.35 |
| Book value per share | 0.4573 |
|---|---|
| Tangible book value per share | 0.2859 |
More ▼
Balance sheet in GBPView more
| Current ratio | 4.85 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0293 |
|---|---|
| Total debt/total capital | 0.0284 |
More ▼
Growth rates in GBP
Year on year, growth in earnings per share excluding extraordinary items dropped -346.49%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -5,086.15 |
